Cart
sales@molnova.com
NITD-349
CAS No. 1473450-62-2
NITD-349( NITD349 )
Catalog No. M12026 CAS No. 1473450-62-2
NITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | Get Quote |
|
| 5MG | 65 | Get Quote |
|
| 10MG | 110 | Get Quote |
|
| 25MG | 200 | Get Quote |
|
| 50MG | 335 | Get Quote |
|
| 100MG | 500 | Get Quote |
|
| 500MG | 1098 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNITD-349
-
NoteResearch use only, not for human use.
-
Brief DescriptionNITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv.
-
DescriptionNITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv; shows potent activity against both drug-sensitive and multidrug-resistant clinical isolates of Mtb; demonstrates effectivity in treating both acute and chronic Mtb infections in mouse efficacy models.
-
In VitroNITD-349 shows bactericidal activity against in vitro replicating Mycobacterium tuberculosis (Mtb) and also are active against intramacrophage Mtb. Kill kinetic analysis of these compounds showed both concentration- and time-dependent killing of Mtb cells with 3- to 4-log colony-forming unit (CFU) reductionwithin 3 days of treatment. The cidal activity profile of NITD-304 is similar to that of isoniazid for which rapid killing is noticed at concentrations greater than 0.2 μM. The MIC activity of NITD349 against various MDR Mtb strains ranges from 0.04 to 0.08 μM. NITD-349 shows high permeability and moderate in vitro metabolic clearance in mouse and human hepatic microsomes.
-
In VivoIn the acute murine efficacy modelNITD-349 shows favorable oral pharmacokinetic (PK) properties in rodents and dogs and are efficacious in mouse models of both acute and chronic Mycobacterium tuberculosis infection. In the acute murine efficacy model, treatment of mice with NITD-349 at doses of 12.5 and 50 mg/kg resulted in 0.9- and 3.4-log CFU reduction in lung tissue. In an established infection mouse model, after 2 weeks of treatment, the efficacy of NITD-349 is comparable to the first-line TB drug rifampicin and is better than ethambutol. Four weeks of treatment at 100 mg/kg with NITD-349 results in 2.38-log CFU reductions.
-
SynonymsNITD349
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1473450-62-2
-
Formula Weight306.36
-
Molecular FormulaC17H20F2N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 310 mg/mL 1011.91 mM
-
SMILESCC1(CCC(CC1)NC(=O)C2=CC3=C(N2)C=C(C=C3F)F)C
-
Chemical NameN-(4,4-dimethylcyclohexyl)-4,6-difluoro-1H-indole-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rao SP, et al. Sci Transl Med. 2013 Dec 4;5(214):214ra168.
molnova catalog
related products
-
Lactoferrin 17-41
This is amino acids 17 to 41 fragment of lactoferrin, known as lactoferricin B. This peptide shows anti-fungal properties in combination of other anti-fungal agents.Candida Albicans is one of the targets of the lactoferricin B.
-
Calcimycin
Calcimycin is an ionophorous, polyether carboxylic antibiotic from Streptomyces chartreusensis.?It binds and transports calcium and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria.?The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.?
-
Macranthoside B
Macranthoside B Iis a natural product?isolated from Flos Lonicerae possesses anti-bacterial activity.
